(MedPage Today) — Women had worse outcomes than men at similar levels of Alzheimer’s disease pathology, data from a multi-cohort analysis suggested.
When amyloid-beta was present, women had higher baseline phosphorylated tau 217 (p-tau217) levels…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
